Practical considerations for prostate hypofractionation in the developing world
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Practical considerations for prostate hypofractionation in the developing world
Authors
Keywords
-
Journal
Nature Reviews Urology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-08-13
DOI
10.1038/s41585-021-00498-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stereotactic Body Radiotherapy for High-Risk Localized CARcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients
- (2021) Ritchell van Dams et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Hypofractionated radiotherapy in the real-world setting: An international ESTRO-GIRO survey
- (2021) Danielle Rodin et al. RADIOTHERAPY AND ONCOLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Surveying the Challenges to Improve Linear Accelerator-based Radiation Therapy in Africa: a Unique Collaborative Platform of All 28 African Countries Offering Such Treatment
- (2021) T.A. Ige et al. CLINICAL ONCOLOGY
- Prostate Fiducial Marker Placement in Patients on Anticoagulation: Feasibility Prior to Prostate SBRT
- (2020) Michelle Iocolano et al. Frontiers in Oncology
- 1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment
- (2020) Filippo Alongi et al. Radiation Oncology
- Electromagnetic Transponder Localization and Real-Time Tracking for Prostate Cancer Radiation Therapy: Clinical Impact of Metallic Hip Prostheses
- (2020) Marta Bottero et al. Practical Radiation Oncology
- NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer
- (2020) William A. Hall et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Stereotactic body radiotherapy versus conventional/moderate fractionated radiation therapy with androgen deprivation therapy for unfavorable risk prostate cancer
- (2020) Sagar A. Patel et al. Radiation Oncology
- Considering benefit and risk before routinely recommending SpaceOAR
- (2020) William A Hall et al. LANCET ONCOLOGY
- The Financial Impact of Hypofractionated Radiation for Localized Prostate Cancer in the United States
- (2019) Assaf Moore et al. Journal of Oncology
- Dose Escalation for Prostate Adenocarcinoma: A Long-Term Update on the Outcomes of a Phase 3, Single Institution Randomized Clinical Trial
- (2019) Dario Pasalic et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies
- (2019) William C. Jackson et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- MR-guidance in clinical reality: current treatment challenges and future perspectives
- (2019) S. Corradini et al. Radiation Oncology
- Important Technical Considerations for Implementing the ASTRO/ASCO/AUA Prostate Cancer Hypofractionated Radiation Guideline
- (2019) Michael J. LaRiviere et al. Practical Radiation Oncology
- Global palliative radiotherapy: a framework to improve access in resource-constrained settings
- (2019) Shekinah N. C. Elmore et al. Annals of Palliative Medicine
- Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
- (2019) Anders Widmark et al. LANCET
- Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial
- (2019) Douglas H Brand et al. LANCET ONCOLOGY
- A treatment planning study comparing IMRT techniques and cyber knife for stereotactic body radiotherapy of low-risk prostate carcinoma
- (2019) Sergiu Scobioala et al. Radiation Oncology
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017
- (2019) et al. JAMA Oncology
- Ultra-hypofractionated radiation therapy for unfavourable intermediate-risk and high-risk prostate cancer is safe and effective: 5-year outcomes of a phase II trial
- (2019) Victor A. Macias et al. BJU INTERNATIONAL
- Cancer Deaths due to Lack of Universal Access to Radiotherapy in the Brazilian Public Health System
- (2018) L.C. Mendez et al. CLINICAL ONCOLOGY
- Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial
- (2018) Abdenour Nabid et al. EUROPEAN UROLOGY
- Are We Now Able to Define Guidelines for Moderate Hypofractionation in Prostate Cancer Radiation Therapy?
- (2018) David J. Brenner et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Magnetic Resonance Imaging-Guided Adaptive Radiation Therapy: A “Game Changer” for Prostate Treatment?
- (2018) Angela U. Pathmanathan et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options
- (2018) Martin G. Sanda et al. JOURNAL OF UROLOGY
- Radiotherapy for prostate cancer – Does daily image guidance with tighter margins improve patient reported outcomes compared to weekly orthogonal verified irradiation? Results from a randomized controlled trial
- (2018) Hanne Tøndel et al. RADIOTHERAPY AND ONCOLOGY
- ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer
- (2018) Carl Salembier et al. RADIOTHERAPY AND ONCOLOGY
- Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer
- (2018) Jeff M. Michalski et al. JAMA Oncology
- Machine Learning in Radiation Oncology: Opportunities, Requirements, and Needs
- (2018) Mary Feng et al. Frontiers in Oncology
- Daily versus weekly prostate cancer image-guided radiotherapy: Phase 3 multicenter randomized trial
- (2018) Renaud de Crevoisier et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Stereotactic Body Radiotherapy for Primary Prostate Cancer
- (2018) Gargi Kothari et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Clinical Application of a Novel Voxel- and Machine Learning-Based Automated Planning Method for Prostate Volumetric Arc Radiation Therapy
- (2018) A. Berlin et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial
- (2018) James W Denham et al. LANCET ONCOLOGY
- Moderate Hypofractionation in High-Risk, Organ-Confined Prostate Cancer: Final Results of a Phase III Randomized Trial
- (2017) Giorgio Arcangeli et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer
- (2017) Charles N. Catton et al. JOURNAL OF CLINICAL ONCOLOGY
- Implanted fiducial markers are no longer needed for prostate cancer radiotherapy
- (2017) Christopher F. Njeh et al. MEDICAL PHYSICS
- Cost evaluation to optimise radiation therapy implementation in different income settings: A time-driven activity-based analysis
- (2017) Jacob Van Dyk et al. RADIOTHERAPY AND ONCOLOGY
- Challenges and Prospects for Providing Radiation Oncology Services in Africa
- (2017) Onyinye Balogun et al. SEMINARS IN RADIATION ONCOLOGY
- Intensity-modulated radiotherapy reduces toxicity with similar biochemical control compared with 3-dimensional conformal radiotherapy for prostate cancer: A randomized clinical trial
- (2016) Gustavo Arruda Viani et al. CANCER
- Estimating the costs of intensity-modulated and 3-dimensional conformal radiotherapy in Ontario
- (2016) J.H.E Yong et al. Current Oncology
- Cost-effectiveness analysis of intensity-modulated radiation therapy with normal and hypofractionated schemes for the treatment of localised prostate cancer
- (2016) A.T. Zemplényi et al. EUROPEAN JOURNAL OF CANCER CARE
- Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries
- (2016) Martin C.S. Wong et al. EUROPEAN UROLOGY
- Macroscopic Hematuria After Conventional or Hypofractionated Radiation Therapy: Results From a Prospective Phase 3 Study
- (2016) Giuseppe Sanguineti et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Closing the Cancer Divide Through Ubuntu: Information and Communication Technology-Powered Models for Global Radiation Oncology
- (2016) Wilfred Ngwa et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From 2 Prospective Cohorts
- (2016) Ruud C. Wortel et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer
- (2016) W. Robert Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial
- (2016) Shafak Aluwini et al. LANCET ONCOLOGY
- Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial
- (2016) Luca Incrocci et al. LANCET ONCOLOGY
- Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
- (2016) David Dearnaley et al. LANCET ONCOLOGY
- Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
- (2016) Jenny L. Donovan et al. NEW ENGLAND JOURNAL OF MEDICINE
- 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
- (2016) Freddie C. Hamdy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Estimation of the optimal utilisation rates of radical prostatectomy, external beam radiotherapy and brachytherapy in the treatment of prostate cancer by a review of clinical practice guidelines
- (2016) Stephen R. Thompson et al. RADIOTHERAPY AND ONCOLOGY
- The economic effect of using magnetic resonance imaging and magnetic resonance ultrasound fusion biopsy for prostate cancer diagnosis
- (2016) Ryan C. Hutchinson et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer
- (2015) Ruggero Ruggieri et al. BRITISH JOURNAL OF RADIOLOGY
- Need for Radiotherapy in Low and Middle Income Countries – The Silent Crisis Continues
- (2015) E.H. Zubizarreta et al. CLINICAL ONCOLOGY
- Potential for Information and Communication Technologies to Catalyze Global Collaborations in Radiation Oncology
- (2015) Wilfred Ngwa et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy
- (2015) Neil Mariados et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial
- (2015) Almudena Zapatero et al. LANCET ONCOLOGY
- Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial
- (2015) Shafak Aluwini et al. LANCET ONCOLOGY
- Expanding global access to radiotherapy
- (2015) Rifat Atun et al. LANCET ONCOLOGY
- No Need to Wait: Fiducial Migration in Immediate Versus Delayed Simulation for Prostate IGRT
- (2014) J.M. Linam et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radiation Therapy Infrastructure and Human Resources in Low- and Middle-Income Countries: Present Status and Projections for 2020
- (2014) Niloy R. Datta et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Addressing the Growing Cancer Burden in the Wake of the AIDS Epidemic in Botswana: The BOTSOGO Collaborative Partnership
- (2014) Jason A. Efstathiou et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radiation Oncology in Africa: Improving Access to Cancer Care on the African Continent
- (2014) Brandon J. Fisher et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Bringing Global Access to Radiation Therapy: Time for a Change in Approach
- (2014) David A. Jaffray et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- International Outreach: What Is the Responsibility of ASTRO and the Major International Radiation Oncology Societies?
- (2014) Nina A. Mayr et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Risk of Late Toxicity in Men Receiving Dose-Escalated Hypofractionated Intensity Modulated Prostate Radiation Therapy: Results From a Randomized Trial
- (2014) Karen E. Hoffman et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial
- (2014) J Athene Lane et al. LANCET ONCOLOGY
- PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markers
- (2014) Christoph Oehler et al. Radiation Oncology
- Estimating the demand for radiotherapy from the evidence: A review of changes from 2003 to 2012
- (2014) Michael B. Barton et al. RADIOTHERAPY AND ONCOLOGY
- The Technique, Resources and Costs of Stereotactic Body Radiotherapy of Prostate Cancer
- (2014) Waseem Sharieff et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Comparison of Image-guided Radiotherapy Technologies for Prostate Cancer
- (2013) Satya Das et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Comparison of Biochemical and Toxicity Outcomes From a Contemporaneous Cohort Study of Low-Risk Prostate Cancer Treated With Different Radiation Techniques
- (2013) D. Loblaw et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Preliminary Toxicity Analysis of 3-Dimensional Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy on the High-Dose Arm of the Radiation Therapy Oncology Group 0126 Prostate Cancer Trial
- (2013) Jeff M. Michalski et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Randomized Trial of Hypofractionated External-Beam Radiotherapy for Prostate Cancer
- (2013) Alan Pollack et al. JOURNAL OF CLINICAL ONCOLOGY
- Status of radiotherapy resources in Africa: an International Atomic Energy Agency analysis
- (2013) May Abdel-Wahab et al. LANCET ONCOLOGY
- Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study
- (2013) Filippo Alongi et al. Radiation Oncology
- A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients
- (2013) Darius Norkus et al. Radiation Oncology
- Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials
- (2013) Christopher R. King et al. RADIOTHERAPY AND ONCOLOGY
- Cost-effectiveness Analysis of SBRT Versus IMRT for Low-risk Prostate Cancer
- (2012) David J. Sher et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis
- (2012) Matthew R. Cooperberg et al. BJU INTERNATIONAL
- Patient-reported complications from fiducial marker implantation for prostate image-guided radiotherapy
- (2012) S Gill et al. BRITISH JOURNAL OF RADIOLOGY
- Cost-effectiveness of Intensity-modulated Radiotherapy in Prostate Cancer
- (2012) J.H.E. Yong et al. CLINICAL ONCOLOGY
- A Model of the Cost-effectiveness of Intensity-modulated Radiotherapy in Comparison with Three-dimensional Conformal Radiotherapy for the Treatment of Localised Prostate Cancer
- (2012) S.R. Hummel et al. CLINICAL ONCOLOGY
- Comparative Cost-Effectiveness of Stereotactic Body Radiation Therapy Versus Intensity-Modulated and Proton Radiation Therapy for Localized Prostate Cancer
- (2012) Anju Parthan et al. Frontiers in Oncology
- Cost-Effectiveness Analysis of Stereotactic Body Radiation Therapy Versus Intensity-Modulated Radiation Therapy: An Emerging Initial Radiation Treatment Option for Organ-Confined Prostate Cancer
- (2012) Joseph C. Hodges et al. Journal of Oncology Practice
- Hypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma
- (2011) Sean M. McBride et al. CANCER
- Geographic Analysis of the Radiation Oncology Workforce
- (2011) Sanjay Aneja et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase I Dose-Escalation Study of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer
- (2011) Thomas P. Boike et al. JOURNAL OF CLINICAL ONCOLOGY
- Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial
- (2011) James W Denham et al. LANCET ONCOLOGY
- Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer
- (2011) Christopher U. Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- Socioeconomic inequalities in the use of radiotherapy for rectal cancer: A nationwide study
- (2010) L.I. Olsson et al. EUROPEAN JOURNAL OF CANCER
- Estimating the Need for Radiotherapy for Patients With Prostate, Breast, and Lung Cancers: Verification of Model Estimates of Need With Radiotherapy Utilization Data From British Columbia
- (2010) Scott Tyldesley et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Burden of Prostate Cancer in Southwestern Nigeria
- (2010) Tajudeen A. Badmus et al. UROLOGY
- Stereotactic body radiotherapy for organ-confined prostate cancer
- (2010) Alan J Katz et al. BMC Urology
- Duration of Androgen Suppression in the Treatment of Prostate Cancer
- (2009) Michel Bolla et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial Comparing Hypofractionated and Conventionally Fractionated Three-Dimensional External-Beam Radiotherapy for Localized Prostate Adenocarcinoma
- (2009) Darius Norkus et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Image Guided Radiotherapy to the Prostate after Implantation of Gold Fiducials: Is it Necessary to Wait 7 Days for Planning?
- (2008) A. Havnen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Androgen Suppression and Radiation vs Radiation Alone for Prostate Cancer
- (2008) Anthony V. D’Amico et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- MRI/linac integration
- (2007) Jan J.W. Lagendijk et al. RADIOTHERAPY AND ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started